Rapp-Hodgkin ectodermal dysplasia syndrome: the clinical and molecular overlap with Hay-Wells syndrome

Area of Science:

• Genetics
• Molecular Biology
• Developmental Biology

Background:

• Ectodermal dysplasia disorders, including Rapp-Hodgkin syndrome (RHS), present with complex clinical features affecting ectodermal structures.
• Genetic mutations, particularly in the p63 gene, are increasingly recognized as causative agents in these syndromes.

Observation:

• Clinical examination of a 7-month-old girl and her mother revealed features consistent with RHS, including cleft palate, abnormal facial features, and developmental issues.
• Molecular analysis identified a novel heterozygous frameshift mutation (1721delC) in exon 14 of the p63 gene in both affected individuals.

Findings:

• The identified 1721delC mutation is a pathogenic p63 gene mutation, the seventh reported in RHS, leading to altered p63 protein isoforms.
• This mutation is predicted to disrupt the transactivation inhibitory domain, resulting in a gain-of-function for specific p63 transcription factor isoforms.
• The findings contribute to the growing p63 mutation database, highlighting significant molecular overlap between RHS and Hay-Wells syndrome.

Implications:

• The discovery of this novel p63 mutation further elucidates the genetic underpinnings of ectodermal dysplasias.
• The molecular similarities suggest that Rapp-Hodgkin syndrome and Hay-Wells syndrome may represent a spectrum of the same disorder.
• This research aids in understanding p63-related disorders and may inform future diagnostic and therapeutic strategies.